Review of Volodymyr Shvadchak on inhibitors of α-synuclein amyloid fibril growth was recently published in The Chemical Record journal (IF=6.9)
Growth of α-synuclein amyloid fibrils is the key process of Parkinson’s disease, the second most common neurodegenerative disorder in the world affecting predominantly old people. The disease is yet incurable and all available treatments are only symptomatic. It stimulates a read more